Comparison of Atomized Sublingual Dexmedetomidine and Oral Midazolam as Preanaesthetic Medication in Children: A Prospective, Double Blind, Randomised Control Trial

Kasturba Hopsital Manipal0 sites60 target enrollmentTBD

Overview

Phase: 未知
Intervention: Not specified
Conditions: Health Condition 1: null- Any child between the ages of 3 years to 7 years, weighing between 10-20 kilograms, undergoing elective minor surgery.
Sponsor: Kasturba Hopsital Manipal
Enrollment: 60
Status: Completed
Last Updated: 4 years ago

No summary available.

Registry

who.int

Start Date

TBD

End Date

February 28, 2018

Last Updated

4 years ago

Study Type

Interventional

Sponsor

Kasturba Hopsital Manipal

•American Society of Anaesthesiologists Physical Status (ASA PS) 1 and 2, Weight 10 to 20 kg, Elective minor surgery under general anesthesia

•American Society of Anesthesiologists Physical Status (ASA PS) 3 and 4, Weight \< 10 kg or \> 20 kg, Known allergy or hypersensitivity to dexmedetomidine, Parental/ Guardian refusal, Severe developmental delay or behavioural problems, Emergency cases, Cardiac arrhythmia or congenital heart disease, Surgeries more than 4 hour duration, Haemodynamic or respiratory instability, Children at risk for airway obstruction (obstructive sleep apnoea or a craniofacial syndrome), Any treatment with sedatives or anticonvulsants, Children who spit, vomited or refused sublingual administration of medication will also be excluded from the study.